Compile Data Set for Download or QSAR
Report error Found 190 Enz. Inhib. hit(s) with all data for entry = 10080
TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512565(WO2021219089, INSCoV-517)
Affinity DataEC50:  3.22E+3nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512573(WO2021219089, INSCoV-517A)
Affinity DataEC50:  1.11E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512774(WO2021219089, INCoV-600J (1) | WO2021219089, INCoV...)
Affinity DataEC50:  1.42E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512776(WO2021219089, INCoV-600K)
Affinity DataEC50:  1.45E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512777(WO2021219089, INCoV-600K (1))
Affinity DataEC50:  1.14E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512815(WO2021219089, INSCoV-601G)
Affinity DataEC50:  1.02E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512831(WO2021219089, INSCoV-601I)
Affinity DataEC50:  1.11E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512832(WO2021219089, INSCoV-601I (1))
Affinity DataEC50:  1.41E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512694(WO2021219089, INSCoV-614 (1B))
Affinity DataEC50:  2.23E+3nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM429505(Remdesivir | med.21724, Compound 178 | US202400347...)
Affinity DataEC50:  7.86E+3nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM22985(Aralen | Chlorochin | CHLOROQUINE PHOSPHATE | Chlo...)
Affinity DataEC50:  7.35E+3nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM50180655(CHEBI:31781 | A-157378-0 | A-157378.0 | ABT-378 | ...)
Affinity DataEC50:  1.39E+4nMAssay Description:SARS-CoV-2 was provided by Korea Centers for Disease Control and Prevention (KCDC) . Vero cells were acquired from the ATCC and maintained in the Dul...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512574(WO2021219089, INSCoV-517A (1A))
Affinity DataIC50: 30nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512875(WO2021219089, INSCoV-601Q (1A))
Affinity DataIC50: 39nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512777(WO2021219089, INCoV-600K (1))
Affinity DataIC50: 50nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512832(WO2021219089, INSCoV-601I (1))
Affinity DataIC50: 50nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512687(WO2021219089, INSCoV-601S (1A))
Affinity DataIC50: 60nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512694(WO2021219089, INSCoV-614 (1B))
Affinity DataIC50: 60nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512817(WO2021219089, INSCoV-601G (1))
Affinity DataIC50: 60nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512841(WO2021219089, INSCoV-601K (1))
Affinity DataIC50: 60nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512831(WO2021219089, INSCoV-601I)
Affinity DataIC50: 62nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512774(WO2021219089, INCoV-600J (1) | WO2021219089, INCoV...)
Affinity DataIC50: 63nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512587(WO2021219089, INSCoV-517C (3))
Affinity DataIC50: 70nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512878(WO2021219089, INSCoV-601Q (1B))
Affinity DataIC50: 71nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512776(WO2021219089, INCoV-600K)
Affinity DataIC50: 78nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512566(WO2021219089, INSCoV-517 (1))
Affinity DataIC50: 80nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512815(WO2021219089, INSCoV-601G)
Affinity DataIC50: 80nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512573(WO2021219089, INSCoV-517A)
Affinity DataIC50: 90nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512891(WO2021219089, INSCoV-601S)
Affinity DataIC50: 90nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512829(WO2021219089, INSCoV-601H)
Affinity DataIC50: 100nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512839(WO2021219089, INSCoV-601K)
Affinity DataIC50: 100nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512581(WO2021219089, INSCoV-517C)
Affinity DataIC50: 110nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512773(WO2021219089, INCoV-600J)
Affinity DataIC50: 110nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512834(WO2021219089, INSCoV-601J)
Affinity DataIC50: 120nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512854(WO2021219089, INSCoV-601N)
Affinity DataIC50: 120nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512879(WO2021219089, INSCoV-601R)
Affinity DataIC50: 120nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512814(WO2021219089, INSCoV-601F)
Affinity DataIC50: 130nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512865(WO2021219089, INSCoV-601N (1))
Affinity DataIC50: 130nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512870(WO2021219089, INSCoV-601P (1A))
Affinity DataIC50: 140nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512885(WO2021219089, INSCoV-601R (1A))
Affinity DataIC50: 140nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512872(WO2021219089, INSCoV-601Q)
Affinity DataIC50: 150nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512761(WO2021219089, INCoV-600C (2B))
Affinity DataIC50: 160nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512580(WO2021219089, INSCoV-517B)
Affinity DataIC50: 170nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512690(WO2021219089, INSCoV-601T)
Affinity DataIC50: 170nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512736(WO2021219089, INCoV-600B (2A))
Affinity DataIC50: 170nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512703(WO2021219089, INSCoV-614A (1B) | WO2021219089, INS...)
Affinity DataIC50: 180nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512735(WO2021219089, INCoV-600B (2))
Affinity DataIC50: 190nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512844(WO2021219089, INSCoV-601K (2))
Affinity DataIC50: 190nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512757(WO2021219089, INCoV-600C (2))
Affinity DataIC50: 200nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

TargetReplicase polyprotein 1ab(2019-nCoV)
Insilico Medicine Ip

WIPO
LigandPNGBDBM512833(WO2021219089, INSCoV-601I (2))
Affinity DataIC50: 210nMAssay Description:he C-His6-tagged SARS-CoV-2 M PRO (NC_045512) was cloned, expressed in E. coli and purified by WuXi. The substrate of Dabcyl-KTSAVLQ‖SGFRKME- (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/27/2022
Entry Details
WIPO WO2021219089

Displayed 1 to 50 (of 190 total ) | Next | Last >>
Jump to: